Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Accumulated Expenses (2016 - 2026)

Innoviva filings provide 16 years of Accumulated Expenses readings, the most recent being $3.7 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 7.83% to $3.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.7 million, a 7.83% increase, with the full-year FY2025 number at $3.7 million, up 7.83% from a year prior.
  • Accumulated Expenses hit $3.7 million in Q4 2025 for Innoviva, up from $231000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $17.6 million in Q3 2024 to a low of $231000.0 in Q3 2025.
  • Median Accumulated Expenses over the past 5 years was $3.4 million (2023), compared with a mean of $3.8 million.
  • Biggest five-year swings in Accumulated Expenses: surged 1326.8% in 2021 and later plummeted 98.69% in 2025.
  • Innoviva's Accumulated Expenses stood at $4.2 million in 2021, then soared by 93.21% to $8.0 million in 2022, then tumbled by 75.97% to $1.9 million in 2023, then surged by 77.49% to $3.4 million in 2024, then grew by 7.83% to $3.7 million in 2025.
  • The last three reported values for Accumulated Expenses were $3.7 million (Q4 2025), $231000.0 (Q3 2025), and $4.8 million (Q2 2025) per Business Quant data.